Home / Insurance / Does Express Scripts Cover Semaglutide? Insurance ...
MC
Reviewed by Marcus Chen Updated February 20, 2026

Does Express Scripts Cover Semaglutide? Insurance Guide 2026

Accessing semaglutide through Express Scripts in 2026 requires navigating a complex insurance landscape. As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide is FDA-approved for type 2 diabetes (under brands like Ozempic® and Wegovy®) and chronic weight management (Wegovy®). However, coverage depends on your plan’s formulary, diagnosis, and prior authorization requirements. This guide provides evidence-based insights into Express Scripts’ semaglutide coverage, cost structures, and appeal strategies to help patients and providers optimize access.

Does Express Scripts Cover Semaglutide for Diabetes?

Express Scripts, one of the largest pharmacy benefit managers (PBMs) in the U.S., typically covers semaglutide for type 2 diabetes under its standard formularies, but restrictions apply. Semaglutide (Ozempic®) is listed on Express Scripts’ National Preferred Formulary (NPF) as a Tier 3 medication, meaning it requires a higher copay than generic alternatives like metformin. Coverage is contingent on a confirmed diagnosis of type 2 diabetes and failure of first-line therapies (e.g., metformin, sulfonylureas).

A 2023 study in Diabetes Care found that semaglutide reduces HbA1c by 1.5–2.0% and lowers cardiovascular risk in diabetic patients, justifying its inclusion in formularies. However, Express Scripts may require step therapy, mandating trials of less expensive GLP-1 agonists (e.g., liraglutide) before approving semaglutide. Patients with commercial insurance through employers like Cigna or Anthem (which use Express Scripts) often qualify, but Medicare Part D plans vary by state.

To confirm coverage, check your plan’s formulary or use Express Scripts’ online tool. If denied, providers can submit clinical documentation (e.g., HbA1c levels, prior medication failures) to support medical necessity.

Does Express Scripts Cover Semaglutide for Weight Loss?

Express Scripts’ coverage of semaglutide for weight loss (Wegovy®) is more restrictive than for diabetes. Wegovy® is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related comorbidities (e.g., hypertension, dyslipidemia). However, Express Scripts often classifies it as a non-preferred or specialty drug, leading to higher out-of-pocket costs or outright denials.

A 2021 NEJM study demonstrated that semaglutide (2.4 mg weekly) led to a 15% mean weight loss over 68 weeks, outperforming older weight-loss drugs. Despite this, Express Scripts may require prior authorization, proof of failed lifestyle interventions (e.g., diet/exercise programs), or enrollment in a weight-management program. Some plans exclude anti-obesity medications entirely, citing cost concerns.

Patients with commercial insurance may have better luck than those with Medicare or Medicaid, as federal programs often exclude weight-loss drugs. If denied, providers can appeal by submitting BMI records, comorbid conditions, and evidence of prior weight-loss attempts. Express Scripts’ coverage decisions are plan-specific, so reviewing your policy’s drug list is critical.

How Much Does Semaglutide Cost With Express Scripts?

The cost of semaglutide with Express Scripts varies widely based on insurance type, formulary tier, and dosage. Without insurance, semaglutide (Ozempic® or Wegovy®) retails for $1,000–$1,500 per month. With Express Scripts coverage, copays typically range from $25–$150 per month for diabetes (Tier 3) and $50–$300 for weight loss (Tier 4 or specialty tier).

A 2024 analysis in JAMA Health Forum found that PBMs like Express Scripts negotiate rebates with manufacturers, reducing net costs by 30–50%. However, these savings may not translate to lower patient copays. For example:

  • Commercial insurance (employer-sponsored): $25–$75 copay for Ozempic®; $100–$300 for Wegovy®.
  • Medicare Part D: 25–33% coinsurance (e.g., $250–$400/month) after deductible.
  • High-deductible plans: Full retail price until deductible is met.

Express Scripts’ Patient Assistance Program (PAP) may offer discounts for uninsured or underinsured patients, but eligibility is income-based. Additionally, Novo Nordisk’s savings cards can reduce copays to $25 for 3 months for eligible commercial insurance holders. Always verify costs using Express Scripts’ price estimator tool.

Semaglutide Prior Authorization for Express Scripts

Prior authorization (PA) is a standard requirement for semaglutide under Express Scripts, designed to ensure cost-effective use. For diabetes (Ozempic®), PA criteria typically include:

  1. Diagnosis of type 2 diabetes (ICD-10 code E11.xx).
  2. Failure of metformin or sulfonylureas (documented intolerance or inadequate glycemic control).
  3. HbA1c >7.0% despite lifestyle modifications.

For weight loss (Wegovy®), PA requirements are stricter:

  1. BMI ≥30 or ≥27 with comorbidities (e.g., hypertension, sleep apnea).
  2. Documented participation in a 6–12-month weight-loss program (e.g., diet, exercise, behavioral therapy).
  3. Prior use of less expensive weight-loss drugs (e.g., phentermine, orlistat) without success.

A 2022 American Journal of Managed Care study found that 30% of GLP-1 PA requests are initially denied, often due to incomplete documentation. To improve approval odds, providers should:

  • Submit detailed clinical notes (e.g., weight/BMI trends, lab results).
  • Include prior medication trials with dates and outcomes.
  • Use Express Scripts’ PA portal for faster processing (average turnaround: 3–5 days).

If denied, providers can request a peer-to-peer review with an Express Scripts medical director.

How to Get Express Scripts to Cover Semaglutide

Securing Express Scripts coverage for semaglutide requires a strategic, evidence-based approach. Follow these steps to maximize approval chances:

  1. Verify Formulary Status

    • Check if semaglutide is listed on your plan’s formulary via Express Scripts’ website. If it’s a non-preferred drug, request a formulary exception citing medical necessity.

  2. Gather Clinical Documentation

    • For diabetes: Provide HbA1c levels, prior medication failures, and hypoglycemia risk (if applicable).
    • For weight loss: Submit BMI records, comorbid conditions, and failed weight-loss attempts.

  3. Complete Prior Authorization (PA)

    • Use Express Scripts’ online PA tool or fax forms to your provider. Ensure all fields are filled accurately to avoid delays.

  4. Leverage Manufacturer Support

    • Novo Nordisk’s savings programs (e.g., Ozempic® Savings Card) can reduce copays to $25/month for eligible patients. Express Scripts may also offer temporary coverage while PA is pending.

  5. Appeal Denials

    • If denied, request a reconsideration with additional evidence (e.g., letters of medical necessity). A 2023 Health Affairs study found that 40% of PA denials are overturned on appeal.

  6. Explore Alternative Coverage

    • If Express Scripts denies coverage, check if your plan offers mail-order pharmacies (e.g., Express Scripts Home Delivery) for lower costs.

What to Do If Express Scripts Denies Semaglutide

If Express Scripts denies semaglutide, don’t panic—appeals and alternatives exist. Here’s a step-by-step action plan:

  1. Understand the Denial Reason

    • Common reasons include:
      • Lack of medical necessity (e.g., HbA1c <7.0% for diabetes).
      • Failure to meet step therapy (e.g., not trying metformin first).
      • Plan exclusions (e.g., weight-loss drugs not covered).

  2. Request a Reconsideration

    • Providers can submit a letter of medical necessity with supporting evidence (e.g., lab results, prior treatment failures). A 2024 Journal of General Internal Medicine study found that detailed appeals increase approval rates by 50%.

  3. Peer-to-Peer Review

    • If the initial appeal fails, request a peer-to-peer discussion between your provider and an Express Scripts medical director. This often resolves disputes without formal appeals.

  4. External Review

    • If internal appeals fail, request an independent external review through your state’s insurance department. This is a patient right under the Affordable Care Act.

  5. Explore Patient Assistance Programs

    • Novo Nordisk offers free or discounted semaglutide for uninsured/underinsured patients (income limits apply). Express Scripts’ Patient Assistance Program may also help.

  6. Consider Alternatives

    • If semaglutide remains denied, discuss tirzepatide (Mounjaro®) or liraglutide (Saxenda®/Victoza®) with your provider. These may have different coverage criteria.

Express Scripts Alternatives If Semaglutide Is Not Covered

If semaglutide isn’t covered by Express Scripts, several alternatives exist—both pharmacological and non-pharmacological:

  1. Other GLP-1 Agonists

    • Tirzepatide (Mounjaro®): A dual GLP-1/GIP agonist approved for diabetes and weight loss. Express Scripts may cover it if semaglutide is denied.
    • Liraglutide (Victoza®/Saxenda®): FDA-approved for diabetes (Victoza®) and weight loss (Saxenda®). Often requires prior authorization but may be easier to obtain.
    • Dulaglutide (Trulicity®): A once-weekly GLP-1 for diabetes, typically covered as a Tier 2 drug.

  2. Non-GLP-1 Weight-Loss Drugs

    • Phentermine/Topiramate (Qsymia®): A stimulant/appetite suppressant combo. Express Scripts may cover it for weight loss if BMI criteria are met.
    • Bupropion/Naltrexone (Contrave®): An antidepressant/opioid antagonist approved for weight loss. Coverage varies by plan.

  3. Lifestyle Interventions

    • Medical Nutrition Therapy (MNT): Covered by many insurance plans, including Medicare, for diabetes/obesity management.
    • Bariatric Surgery: For patients with BMI ≥40 or ≥35 with comorbidities, surgery may be a covered alternative.

  4. Mail-Order Pharmacies

    • Express Scripts’ Home Delivery service may offer lower copays for semaglutide alternatives. Other PBMs (e.g., CVS Caremark, OptumRx) may have different formularies—check if switching plans is an option.

  5. Clinical Trials

    • Novo Nordisk and other manufacturers often run clinical trials for new semaglutide formulations. Participants may access the drug for free.

Frequently Asked Questions

Does Express Scripts cover Semaglutide for weight loss?

Express Scripts may cover semaglutide (Wegovy®) for weight loss, but it’s often restricted to patients with BMI ≥30 or ≥27 with comorbidities. Prior authorization is typically required, and coverage varies by plan. Check your formulary or request a formulary exception if denied.

How much is the Semaglutide copay with Express Scripts?

Copays for semaglutide with Express Scripts range from $25–$150/month for diabetes (Ozempic®) and $50–$300/month for weight loss (Wegovy®). Costs depend on your insurance tier, deductible, and manufacturer savings programs. Use Express Scripts’ price estimator tool for exact figures.

Can I appeal if Express Scripts denies Semaglutide?

Yes—you can appeal an Express Scripts denial by submitting a letter of medical necessity and supporting clinical evidence. If the initial appeal fails, request a peer-to-peer review or external independent review. Many denials are overturned with proper documentation.

Disclaimer from Marcus Chen, PharmD: The information provided is for educational purposes only and does not constitute medical or insurance advice. Coverage policies for semaglutide vary by plan, employer, and state regulations. Always consult your healthcare provider and insurance representative for personalized guidance. Express Scripts’ formulary and prior authorization criteria may change annually.